A Step Toward Shorter, Personalized Therapy for Clarithromycin-Resistant Helicobacter pylori.
作者信息
Kim Seung Young
机构信息
Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul, Korea.
出版信息
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):201-202. doi: 10.7704/kjhugr.2025.0042. Epub 2025 Sep 1.
Abstract
摘要
相似文献
1
A Step Toward Shorter, Personalized Therapy for Clarithromycin-Resistant Helicobacter pylori.迈向针对克拉霉素耐药幽门螺杆菌的更短疗程、个性化治疗的一步。
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):201-202. doi: 10.7704/kjhugr.2025.0042. Epub 2025 Sep 1.
2
Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis.铋剂对耐抗生素幽门螺杆菌菌株根除的疗效：一项系统评价和荟萃分析。
Helicobacter. 2022 Dec;27(6):e12930. doi: 10.1111/hel.12930. Epub 2022 Sep 25.
3
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析：强效酸抑制剂——沃诺拉赞优于质子泵抑制剂，可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
4
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
5
Clinical evaluation of personalized treatment guided by PCR detection from fecal samples: a real-world study.粪便样本PCR检测指导下的个性化治疗的临床评估：一项真实世界研究
Front Cell Infect Microbiol. 2025 Apr 28;15:1519804. doi: 10.3389/fcimb.2025.1519804. eCollection 2025.
6
Clinical evaluation of a novel fecal molecular diagnosis kit (multiplex RT-PCR method) for detecting clarithromycin and fluoroquinolones resistance using stool samples.一种新型粪便分子诊断试剂盒（多重逆转录聚合酶链反应法）用于通过粪便样本检测克拉霉素和氟喹诺酮类耐药性的临床评估。
Front Cell Infect Microbiol. 2025 Jun 23;15:1592612. doi: 10.3389/fcimb.2025.1592612. eCollection 2025.
7
Eradication of for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.根除幽门螺杆菌预防65岁以上成年人阿司匹林相关消化性溃疡出血：HEAT随机对照试验
Health Technol Assess. 2025 Aug;29(42):1-62. doi: 10.3310/LLKF7871.
8
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.治疗前后幽门螺杆菌对抗生素的耐药性：根除失败的发生率。
PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022.
9
Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detection.建立 TaqMan-MGB 探针多重实时 PCR 系统一步法检测左氧氟沙星和克拉霉素耐药幽门螺杆菌。
J Microbiol Methods. 2022 Jan;192:106393. doi: 10.1016/j.mimet.2021.106393. Epub 2021 Dec 14.
10
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta-analysis.基于粪便标本中环丙沙星耐药基因检测的个体化诊断和根除治疗幽门螺杆菌感染：系统评价和荟萃分析。
Helicobacter. 2023 Jun;28(3):e12958. doi: 10.1111/hel.12958. Epub 2023 Feb 24.
本文引用的文献
1
Practical Efficacy of a 1-Week Metronidazole-Based Triple Regimen Plus Bismuth Versus a 2-Week Bismuth-Based Quadruple Regimen for Helicobacter pylori Infection With Clarithromycin-Resistance-Associated Genetic Mutations.基于甲硝唑的一周三联疗法加铋剂与基于铋剂的两周四联疗法治疗伴有克拉霉素耐药相关基因突变的幽门螺杆菌感染的实际疗效比较
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):261-267. doi: 10.7704/kjhugr.2025.0022. Epub 2025 Sep 1.
2
Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study.铋剂四联疗法治疗幽门螺杆菌感染的最佳疗程：一项回顾性研究。
Medicine (Baltimore). 2023 Dec 1;102(48):e36310. doi: 10.1097/MD.0000000000036310.
3
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染：随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
Zotero 插件